Use of isothermal heat conduction microcalorimetry, X-ray diffraction, and optical microscopy for characterisation of crystals grown in steroid combination-containing transdermal drug delivery systems

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 57, Issue 2, 2004, Pages 397-410

  Latsch, Silvia ^a   Selzer, Torsten ^b   Fink, Lothar ^c   Horstmann, Michael ^d   Kreuter, Jörg ^a,c  

^a Inst fur Pharmazeut Technol   (Germany)

^b Baxter Oncology GmbH   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d LTS Lohmann Therapie Systeme AG   (Germany)

Author keywords

Crystallisation; Estradiol; Microcalorimetry; Norethindrone acetate; Transdermal drug delivery system; X ray powder diffraction

Indexed keywords

ESTRADIOL; NORETHISTERONE ACETATE; STEROID;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENTHALPY; MICROCALORIMETRY; MICROSCOPY; TEMPERATURE DEPENDENCE; TRANSDERMAL PATCH; X RAY DIFFRACTION;

EID: 1442310739     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(03)00120-6     Document Type: Article

References (39)

1. Davis A.F., Hadgraft J. Effect of supersaturation on membrane transport: 1. Hydrocortisone acetate. Int. J. Pharm. 76:1991;1-8.
2. Pellett M.A., Davis A.F., Hadgraft J. Effect of supersaturation on membrane transport: 2. Piroxicam. Int. J. Pharm. 111:1994;1-6.
3. Megrab N.A., Williams A.C., Barry B.W. Oestradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation. J. Contr. Rel. 36:1995;277-294.
4. Iervolino M., Raghavan S.L., Hadgraft J. Membrane penetration enhancement of ibuprofen using supersaturation. Int. J. Pharm. 198:2000;229-238.
5. Iervolino M., Cappello B., Raghavan S.L., Hadgraft J. Penetration enhancement of ibuprofen from supersaturated solutions through human skin. Int. J. Pharm. 212:2001;131-141.
6. Stefano F.J.E., Biali F.I., Scasso A.F. Crystallisation in NETA-17β-E2 transdermal patches. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 24:1997;703-704.
7. Variankaval N.E., Jacob K.I., Dinh S.M. Crystallization of β-estradiol in an acrylic transdermal drug delivery system. J. Biomed. Mat. Res. 44:1999;397-406.
8. Lipp R., Müller-Fahrnow A. Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems. Eur. J. Pharm. Biopharm. 47:1999;133-138.
9. Kim J.-H., Choi H.-K. Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int. J. Pharm. 236:2002;81-85.
10. S. Latsch, T. Selzer, L. Fink, J. Kreuter, Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy, Eur. J. Pharm. Biopharm. 56 (2003) 43-52.
11. S. Latsch, T. Selzer, L. Fink, J. Kreuter, Determination of the physical state of norethindrone acetate containing TDDS by isothermal microcalorimetry, X-ray diffraction, and optical microscopy, Eur. J. Pharm. Biopharm. 2003, in press.
12. Kotiyan P.N., Vavia P.R. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol. Eur. J. Pharm. Biopharm. 52:2001;173-180.
13. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm. 184:1999;1-6.
14. Raghavan S.L., Trividic A., Davis A.F., Hadgraft J. Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate. Int. J. Pharm. 193:2000;231-237.
15. Ma X., Taw J., Chiang C.-M. Control of drug crystallization in transdermal matrix system. Int. J. Pharm. 142:1996;115-119.
16. Lipp R. Selection and use of crystallisation inhibitors for matrix-type transdermal drug-delivery systems containing sex steroids. J. Pharm. Pharmacol. 50:1998;1343-1349.
17. Raghavan S.L., Trividic A., Davis A.F., Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int. J. Pharm. 212:2001;213-221.
18. Pellett M.A., Castellano S., Hadgraft J., Davis A.F. The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro. J. Contr. Rel. 46:1997;205-214.
19. Raghavan S.L., Kiepfer B., Davis A.F., Kazarian S.G., Hadgraft J. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. Int. J. Pharm. 221:2001;95-105.
20. Kuhnert-Brandstätter M., Winkler H. Thermoanalytische und IR-spektroskopische Untersuchungen an verschiedenen Kristallformen von Arzneistoffen aus der Östradiol- und Androstangruppe. Sci. Pharm. 44:1976;177-190.
21. Variankaval N.E., Jacob K.I., Dinh S.M. Characterization of crystal forms of β-estradiol - thermal analysis, Raman microscopy, X-ray analysis and solid-state NMR. J. Cryst. Growth. 217:2000;320-331.
22. Harmia T., Speiser P., Kreuter J. A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles. J. Microencapsul. 3:1986;3-12.
23. Lehto V.P., Laine E. A kinetic study of polymorphic transition of anhydrous caffeine with microcalorimeter. Thermochim. Acta. 317:1998;47-58.
24. Fukuoka E., Makita M., Yamamura S. Glassy state of pharmaceuticals. III. Thermal properties and stability of glassy pharmaceuticals and their binary glass systems. Chem. Pharm. Bull. 37:1989;1047-1050.
25. Lehto V.P., Laine E. A kinetic study on crystallization of an amorphous lubricant. Pharm. Res. 14:1997;899-904.
26. Krüger P., Woldt E. The use of an activation energy distribution for the analysis of the recrystallization kinetics of copper. Acta Metall. Mater. 40:1992;2933-2942.
27. Avrami M. Kinetics of phase change. I General theory. J. Chem. Phys. 7:1939;1103-1112.
28. Avrami M. Kinetics of phase change. II Transformation-time relations for random distribution of nuclei. J. Chem. Phys. 8:1940;212-224.
29. Hutchinson B., Jonsson S., Ryde L. On the kinetics of recrystallisation in cold worked metals. Scr. Met. 23:1989;671-676.
30. Pradell T., Crespo C., Clavaguera N., Clavaguera-Mora M.T. Diffusion controlled grain growth in primary crystallization: avrami exponents revisited. J. Phys. Condens. Matter. 10:1998;3833-3844.
31. Schmitt E.A., Law D., Zhang G.Z. Nucleation and crystallization kinetics of hydrated amorphous lactose above glass transition temperature. J. Pharm. Sci. 88:1999;291-296.
32. Ye F., Lu K. Crystallization kinetics of Al-Na-Ni amorphous alloy. J. Non-Cryst. Solids. 262:2000;228-235.
33. Mazzobre M.R., Soto G., Aguilera J.M., Buera M.P. Crystallization kinetics of lactose in systems co-lyofilized with trehalose. Analysis by differential scanning calorimetry. Food Res. Int. 34:2001;903-911.
34. Corrigan D.O., Healy A.M., Corrigan O.I. The effect of spray drying solutions of polyethylene glycol (PEG) and lactose/PEG on their physicochemical properties. Int. J. Pharm. 235:2002;193-205.
35. Pudipeddi M., Sokoloski T.D., Duddu S.P., Carstensen J.T. Calorimetric determination of the heat of precipitation of pseudoephedrine racemic compound - its agreement with the heat of solution. J. Pharm. Sci. 84:1995;1236-1239.
36. Kabasakalian P., Britt E., Yudis M.D. Solubility of some steroids in water. J. Pharm. Sci. 55:1966;642.
37. Lundberg B. Temperature effect on the water solubility and water-octanol partition of some steroids. Acta Pharm. Suec. 16:1979;151-159.
38. Higuchi T., Shih F.-M.L., Kimura T., Rytting J.H. Solubility determination of barely aqueous-soluble organic solids. J. Pharm. Sci. 68:1979;1267-1272.
39. Millard J.W., Alvarez-Núñez F.A., Yalkowsky S.H. Solubilization by cosolvents. Establishing useful constants for the log-linear model. Int. J. Pharm. 245:2002;153-166.